Propose. Together, members of the community can propose to study
and fund a promising treatment,
evaluate the approach, and decide which ones to pursue next.
Develop. Vibe Bio uses the money raised from $VIBE token sales and approved by the community to perform drug development work. This includes clinical trials, pre-clinical development, and manufacturing, to name a few. The economics of each of these drug research programs is shared between the disease-specific patient community and the DAO.
Community. Patients, scientists, and investors come together to make up the Vibe Bio DAO, or decentralized
autonomous organization, the
community of $VIBE token holders.
Sustain. As these treatments are commercialized or are licensed by other pharmaceutical companies, they return capital to the DAO and patient advocacy organizations. Our community can use those returns to fund future projects.
For too many patients with overlooked diseases, the time it would take to develop a cure is longer than the time they have left.
For the first time, we're developing and scaling treatments for rare disorders — and giving patient communities unprecedented control in the process.
To do that, we partner with patient groups to develop treatments that otherwise would languish on a shelf. We leverage innovative sources of funding and build a community of scientists and fellow patients so that no one has to forge the path to a cure alone.
NF2 Biosolutions is a foundation working to develop a therapy for NF2, a rare genetic disorder that causes pain, hearing loss, vision loss, and paralysis. Symptoms worsen when patients reach young adulthood, and the disorder is fatal. NF2 Biosolutions has raised more than $1 million and partnered with ten labs to research a promising gene therapy treatment, but it needed a bigger source of funding to start clinical trials. Vibe Bio is partnering with NF2 Biosolutions to provide that funding and launch Merlin, a biotech company dedicated to finding a cure for NF2. Read more about NF2 Biosolutions here.
Chelsea’s Hope is a foundation dedicated to finding a cure for Lafora disease, which causes seizures and cognitive and physical decline. Most patients pass away within 10 years of the onset of symptoms. Vibe Bio is partnering with Chelsea’s Hope to start new clinical trials and finally find a cure. Together, we have founded New Hope, a biotech company that will build on promising research into potential therapies for Lafora disease to finally get patients the treatment they need. Read more about Chelsea’s Hope here.
Vibe Bio is a community of patients, scientists, and partners committed to identifying promising treatments to overlooked diseases, funding their development in innovative ways, and giving patient communities unprecedented ownership over the new treatments they need.
Vibe Bio partners with patient communities to find treatments for rare and overlooked disorders. Our first two foundation partnerships — Chelsea’s Hope and NF2 Biosolutions — will help develop treatments for rare disorders Lafora disease and NF2.
Together, members of the community can propose to study and fund a promising treatment, evaluate the approach, and approve which ones Vibe pursues next. In this process, independent drug development experts (scientists & researchers) review projects proposed by the community. Their assessments are synthesized and inform the feasibility and potential associated with proposed projects.
We are always eager to connect with patients, families, advocates, scientists, biopharma companies, and others who are as passionate as we are about finding treatments for overlooked diseases. Please contact us here to let us know that you’re interested in working together.
You can join the Vibe community by partnering with us or purchasing our cryptocurrency token, $VIBE. If you’re interested in working together or want more information about our initial token release, please fill out this form.
Cryptocurrency is an exciting area of technology that has created nearly $1T in value over the past decade. We believe that this pool of capital is ideal to support high-potential, transformative projects, like drug development for rare diseases.
For patients and drug developers, there is no financial cost to participate in the Vibe Bio community.
Vibe Bio raises money through $VIBE cryptocurrency token sales, which our community then allocates to perform drug development work. As the treatments we advance are commercialized or are licensed by pharmaceutical companies, they return capital to the DAO and patient advocacy organizations. Our community can use those returns to fund future projects.
Vibe Bio sells the $VIBE token to external investors and converts all proceeds to dollars or dollar-denominated stablecoins. The community approves the expenditure of dollars from the treasury for drug development programs.
The drug development work is performed by experienced drug developers, scientists, contract partners (e.g. contract research organizations, contract manufacturing organizations), and medical establishments (e.g. for clinical trials).
Vibe Bio is building a community of patients, scientists, and partners to identify promising treatments and fund their development in innovative ways, including cryptocurrency token sales. However, crypto is not the only source of capital used to fund drug development programs. Grants and equity investment, among other sources, are also used.
1 in 10 Americans suffer from a rare disease. Vibe Bio is focused on rare diseases because of the urgent need for cures and because of the vibrant and motivated communities who are already organized in pursuing those cures. Vibe Bio is funding and advancing projects that currently are not getting the funding and attention they deserve.
When Vibe Bio founder Alok Tayi and his wife had their first child, she was born very sick and spent a long time suffering in the hospital. The biology behind her conditions is well understood, but there were no therapeutic options available to her. They felt frustrated and alone.
Through that experience, Alok connected with other families with sick children in the NICU and realized that the problem with drug development — especially for rare diseases — is not that we can’t find cures; it’s that we don’t have the funding to do it. That’s what motivated him to create Vibe Bio, which will give patients ownership over the drug development process and a community to support them along the way.